SCHEMBL78599

SCHEMBL78599

CC[C@H](N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL427560 1.00
SCHEMBL2050880 1.00 SLC1A2 (0.61)
SCHEMBL15355765 1.00
SCHEMBL23958 1.00
Hydrogen Peroxide SCHEMBL2783488 1.00
SCHEMBL587531 0.97
SCHEMBL15820001 0.97
Bromide SCHEMBL11723723 0.97
SCHEMBL587047 0.97
SCHEMBL16177042 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 9907 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144882-A1 ANTI-NECTIN-4 ANTIBODY DRUG CONJUGATE AND USE THEREOF BIO-THERA SOLUTIONS, LTD. (CN) 2026-05-28 US claimed
CN-122070294-A Stable vitreous material based on histidine, arginine and glutamic acid amino acids 阵序补丁有限公司 2026-05-19 CN claimed
EP-3869192-B1 METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE HUMAN METABOLOMICS INST INC (CN) 2026-05-13 EP claimed
EP-4737473-A1 NOVEL COMPLEMENT INHIBITOR AND PREPARATION, USE AND PRODUCT THEREOF Liu, Xiaorong (CN) 2026-05-06 EP claimed
US-20260116921-A1 PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES PROTAGONIST THERAPEUTICS INC (US) 2026-04-30 US claimed
EP-4724457-A2 RADIOPHARMACEUTICAL COMPOSITIONS TARGETING GLYPICAN-3 AND USES THEREOF Rayzebio, Inc. (US) 2026-04-15 EP claimed
EP-4724459-A1 PEPTIDE COMPOSITIONS TARGETING GLYPICAN-3 AND USES THEREOF Peptidream Inc (JP) 2026-04-15 EP claimed
US-20260098059-A1 COMPOSITIONS AND METHODS FOR TREATING ENDOMETRIOSIS ENDOMET BIOSCIENCES INC (US) 2026-04-09 US claimed
EP-4720089-A1 COMPOSITIONS AND METHODS FOR IMAGING AND TREATING ENDOMETRIOSIS Endomet Biosciences, Inc. (US) 2026-04-08 EP claimed
US-12590126-B2 Compounds for selective disruption of protein-protein interactions SYNTHEX, INC. (US) 2026-03-31 US claimed
US-4595674-A Pharmaceuticals BAYER AKTIENGESELLSCHAFT (DE) 1986-06-17 US claimed
EP-0183840-A1 IMPROVEMENT IN THE FLAVOR OF ZINC SUPPLEMENTS FOR ORAL USE. GODFREY SCIENCE & DESIGN INC (US) 1986-06-11 EP claimed
EP-0080283-B1 N-CARBOXYALKYLPROLINE-CONTAINING TRIPEPTIDES SMITHKLINE BECKMAN CORPORATION (US) 1986-01-29 EP claimed
WO-1986000004-A1 IMPROVEMENT IN THE FLAVOR OF ZINC SUPPLEMENTS FOR ORAL USE GODFREY SCIENCE & DESIGN, INC. (US) 1986-01-03 WO claimed
US-4456594-A N-Carboxyalkylproline-containing tripeptides SMITHKLINE BECKMAN CORPORATION (US) 1984-06-26 US claimed
EP-0080283-A1 N-carboxyalkylproline-containing tripeptides SMITHKLINE BECKMAN CORPORATION (US) 1983-06-01 EP claimed
EP-0076647-A2 Culture media for cells originating from the immune system HANA Biologics Incorporated (US) 1983-04-13 EP claimed
US-4155762-A ALKALI OR ALKALINE EARTH METAL SALT OF AMINO CARBOXYLIC OR SULFONIC ACID RICOH CO., LTD. (JP) 1979-05-22 US claimed
US-3988307-A ATTACHING AN ALPHA,BETA-UNSATURATED AMINO ACID TO A SOLID SUPPORT; ACIDIC AQUEOUS RELEASE AGENT THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH, EDUCATION AND WELFARE (US) 1976-10-26 US claimed
US-3979457-A ACYLASE DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JA) 1976-09-07 US claimed